These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 7476897)
1. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit. Lanier B; Raddatz R; Bakthavachalam V; Coupry I; Neumeyer JL; Lanier SM Mol Pharmacol; 1995 Oct; 48(4):703-10. PubMed ID: 7476897 [TBL] [Abstract][Full Text] [Related]
2. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney. Ivkovic B; Bakthavachalam V; Zhang W; Parini A; Diz D; Bosch S; Neumeyer JL; Lanier SM Mol Pharmacol; 1994 Jul; 46(1):15-23. PubMed ID: 8058049 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546 [TBL] [Abstract][Full Text] [Related]
4. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B. Raddatz R; Lanier SM Neurochem Int; 1997 Jan; 30(1):109-17. PubMed ID: 9116581 [TBL] [Abstract][Full Text] [Related]
5. Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B. Raddatz R; Parini A; Lanier SM J Biol Chem; 1995 Nov; 270(46):27961-8. PubMed ID: 7499273 [TBL] [Abstract][Full Text] [Related]
10. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1. Limon-Boulez I; Tesson F; Gargalidis-Moudanos C; Parini A J Pharmacol Exp Ther; 1996 Feb; 276(2):359-64. PubMed ID: 8632297 [TBL] [Abstract][Full Text] [Related]
11. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites. Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858 [TBL] [Abstract][Full Text] [Related]
12. Localization of the imidazoline binding domain on monoamine oxidase B. Raddatz R; Parini A; Lanier SM Mol Pharmacol; 1997 Oct; 52(4):549-53. PubMed ID: 9380016 [TBL] [Abstract][Full Text] [Related]
13. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes. Alemany R; Olmos G; García-Sevilla JA Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188 [TBL] [Abstract][Full Text] [Related]
14. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney. King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560 [TBL] [Abstract][Full Text] [Related]
15. Use of high affinity, radioiodinated probes for identification of imidazoline/guanidinium receptive sites. Lanier SM; Lanier B; Bakthavachalam V; McGrath CR; Neumeyer JL Ann N Y Acad Sci; 1995 Jul; 763():106-11. PubMed ID: 7677319 [TBL] [Abstract][Full Text] [Related]
16. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain. Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase-deficient mouse models. Remaury A; Raddatz R; Ordener C; Savic S; Shih JC; Chen K; Seif I; De Maeyer E; Lanier SM; Parini A Mol Pharmacol; 2000 Nov; 58(5):1085-90. PubMed ID: 11040057 [TBL] [Abstract][Full Text] [Related]
18. Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice. Anderson NJ; Seif I; Nutt DJ; Hudson AL; Robinson ES J Neurochem; 2006 Mar; 96(6):1551-9. PubMed ID: 16476082 [TBL] [Abstract][Full Text] [Related]
19. [3H]2-(2-Benzofuranyl)-2-imidazoline, a highly selective radioligand for I2-imidazoline receptor binding sites. Studies in rabbit kidney membranes. Hosseini AR; King PR; Louis WJ; Gundlach AL Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):131-8. PubMed ID: 9007853 [TBL] [Abstract][Full Text] [Related]
20. Relationship between I2 imidazoline binding sites and monoamine oxidase B in liver. Remaury A; Ordener C; Shih J; Parini A Ann N Y Acad Sci; 1999 Jun; 881():32-4. PubMed ID: 10415894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]